---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-000931"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T13:45:00.372249+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Immunic shareholders elect Rudick and Törnsén, ratify auditor, approve share plan amendment

## Summary
- Dr. Richard Rudick and Maria Törnsén elected to three-year terms with ~19.9M votes for each; ~5.65M broker non-votes.
- Baker Tilly Virchow Krause, LLP ratified as independent auditor for 2023; 25.5M for, 75K against, 71K abstain.
- Amendments to 2019 Omnibus Plan approved: shares authorized increased by 4,440,000 to 10,348,871; evergreen provision removed.
- Quorum of 25,616,356 shares represented at meeting out of 44,403,838 entitled to vote.

## SEC filing metadata
- accession: 0001193805-23-000931
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/0001193805-23-000931-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/e618747_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-000931
- JSON: https://secwatch.observer/filing/0001193805-23-000931.json
- Plain text: https://secwatch.observer/filing/0001193805-23-000931.txt

## Key facts
- Shareholder Votes
  IMMUNIC, INC. shareholders approved Ratification of the selection of Baker Tilly Virchow Krause, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-28 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: Proposal 2: Ratification of Appointment of Baker Tilly Virchow Krause, LLP as Independent Registered Public Accounting Firm FOR AGAINST ABSTAIN BROKER NON-VOTES 25,469,440 75,616 71,300 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/0001193805-23-000931-index.htm
- Shareholder Votes
  IMMUNIC, INC. shareholders approved Election of Dr. Richard Rudick and Ms. Maria Törnsén as directors for a three year term expiring at the 2026 annual meeting of stockholders at the 2023-06-28 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: Proposal 1: Election of Directors NOMINEE FOR WITHHELD BROKER NON-VOTES Dr. Richard Rudick 19,855,497 109,841 5,651,018 Ms. Maria Törnsén 19,840,786 124,552 5,651,018
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/0001193805-23-000931-index.htm
- Shareholder Votes
  IMMUNIC, INC. shareholders approved Approve amendments to the Company's 2019 Omnibus Plan to (i) increase the number of common stock authorized for issuance by 4,440,000 shares to a total of 10,348,871 shares, and (ii) remove the evergreen provision at the 2023-06-28 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: Proposal 3: Approve Amendments To the Company’s 2019 Omnibus Plan FOR AGAINST ABSTAIN BROKER NON-VOTES 19,529,897 408,815 26,626 5,651,018
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/0001193805-23-000931-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.